Neural tube defects and folic acid

Indian Pediatrics

Volumn 41, Issue 6, 2004, Pages 577-586

  Gupta, Hema ^a   Gupta, Piyush ^a,b  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; CLINICAL FEATURE; DIETARY INTAKE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FOLIC ACID DEFICIENCY; GENETIC ANALYSIS; HUMAN; NEURAL TUBE DEFECT; REVIEW; SPINA BIFIDA; UNITED STATES; VITAMIN SUPPLEMENTATION;

FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL NUTRITION PHYSIOLOGY;

EID: 3042660724     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Date I, Yagvu Y, Asari S, Ohmoto T. Long term outcome in surgically treated spina bifida cystica. Surg Neurol 1993; 40: 471-475.
2. Hibbard ED, Smithells RW. Folic acid metabolism and human embryopathy. Lancet 1965; 1: 1254.
3. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976; 61: 944-950.
4. Yates JRW, Ferguson Smith MA, Shenkin A, Gunman Rudriguez R, White M, Clarke BJ, et al. Is disordered folate metabolism the basis of genetic predisposition to neural tube defects? Clin Genet 1987; 31: 279-287.
5. Czeizel AE, Dudas ID. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Eng J Med 1992; 327: 1832-1835.
6. Luneley J, Watson L, Watson T, Bover C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Sys Rev 2000; 2: CD 00156.
7. MRC Vitamin Research Group. Prevention of neural tube defects: results of MRC Vitamin Study. Lancet 1991; 338: 131-137.
8. Shibya K, Murray CJI. Congenital anomalies. In: Murray CJL, Lopez AD, editors. Health Divisions of Sex And Reproduction: The Global Burden of Sexually Transmitted Diseases, HIV, Maternal Conditions, Perinatal Disorders and Congenital Anomalies. Vol 3.Boston: Harvard University Press; 1998. P. 455-512.
9. Hall JG, Sollehhdin F. Genetics of neural tube defects. Mental Retard Div Disabil 1999; 4: 269-281.
10. Department of Health. Report from an Expert Advisory Group. Folic acid and the prevention of neural tube defects. London: Department of Health; 1992.
11. Cragan JD, Roberts HE, Edmonds LD. Surveillance for anencephaly and spina bifida and impact of prenatal diagnosis-United States. 1985-1994. Mortal Morb Wkly Rep 1995; 44: 1-3.
12. Larry JM, Edmonds LD. Prevalence of spina bifida at birth - United States 1983-1990. A comparison of two surveillance systems. Mortal Morb Wkly Rep 1996; 45: 15-26.
13. Annual Report. International Clearinghouse' for Birth Defects Monitoring Systems. Rome: International Center for Birth Defects; 1998. P. 100-101.
14. Folate and neural tube defects. Recommendations from a Danish Working Group.Dan Med Bull 1998; 45; 213-217.
15. Berry JR, Ericson D, Li S, Moore LA. Prevention of neural tube defects with folic acid in China. N Engl J Med 1999; 341: 3485-3490.
16. Verma IC. Burden of genetic disorders in India. Indian J Pediatr 2000; 67: 893-898.
17. Mitchell HK, Snell EE, Williams RF. Folic acid: Concentration from spinach. J Am Chem Soc 1994; 66: 267-268.
18. Chanarin L. Folate and cobalamin. Clin Haematol 1985; 14: 629-640.
19. Homocysteine Lowering Trialists Collaboration. Lowering blood homocysteine with folic acid based supplements: meta analysis of randomized trials. BMJ 1998; 316: 894-898.
20. Smithells RW, Sheppard S, Schorah J. Vitamin deficiency and neural tube defects. Arch Dis Child 1976; 51: 944-950.
21. Hoffbrand AV, Newcombe BFA, Mollen DL. Method of assay of red cell folate activity and the value of the assay as a test for folate defieciency. J Clin Pathol 1966; 19: 17-28.
22. Daly LE, Kirke PN, Mollen A, Weir DG, Scott JM. Folate levels and neural tube defects: Implications for prevention. J Am Med Assoc 1996; 274: 1098-1702.
23. Hibbard BM. The role of folic acid in pregnancy. J Obstet Gynaecol Br Commonw 1964; 71: 529-542.
24. Molloy AM, Daly S, Mills JP. Thermolabile variant of 5,10 methylenetetrahydrofolate reductase associated with low red cell folate: applications for folate recommendations. Lancet 1997; 309: 191-193.
25. Gimmermsen AB, Ueland PM, Nesthus I. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia. The Horland homocysteine study. J Clin Invest 1996; 98: 3134-3183.
26. Goldenbergh RL, Tamura T, Cliver SP, Cutter CR, Hoffman CH, Cooper RL et al. Serum folate and fetal growth retardation: a matter of compliance. J Obstet Gynecol 1992; 79: 719-722.
27. Theunissen Steegers RP, Boers GMJ, Trijbels FJM, Eskers TKAB. Neural tube defects and derangement of homocystiene metabolism. N Engl J Med 1991; 43: 199-200.
28. Smithells RW, Nevic NC, Seller MJ. Further exposure of vitamin supplementation for prevention of NTD recurrences. Lancet 1983; 1: 1027-1031.
29. Forrest JD. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol 1994; 170: 1485-1489.
30. Sadler TW. Mechanisms of neural tube closure and defects. Mental Retard Dev Disabil Res Rev 1998; 4: 247-253.
31. Cuskelly GJ, McNaughty H, Scoton JM. Effect of increasing dietary folate on red cell folate: implication for prevention of NTD. Lancet 1996; 347: 656-657.
32. Center for Disease Control and Prevention. Knowledge and use of folic acid by women of child-bearing age. United States 1995. Mortal Morb Wkly Rep 1998; 44: 716-718.
33. Laurah E, Bn Pham, Ala S'dair GWH. Low rate of inadequate folic acid supplementation in well educated women of high socioeconomic states attending genetic clinic. CMAJ 2001; 17: 164-168.
34. March of Dimes. Folic acid and prevention of birth defects. A national survey of pregnancy awareness and behavior among women of childbearing age 1995-2001 Executive Summary.
35. Oleary M, Donnell RM, Jhonson H. Folic acid and prevention of neural tube defects in 2000 improved awareness-low periconceptional uptake. Ir Med J 2002; 95: 289.
36. Gupta P, Gupta A. Awareness regarding use of folic acid for prevention of congenital neural tube defects. Nat Med J India 2000; 13: 105.
37. Melissa R, Susan Iryna LN. Folate intakes and awareness of folate to prevent neural tube defects. A survey in Vancouver, Canada. J Am Dietic Ass 2003; 103; 181-185.
38. Bekkers RCM, Eskers TKAB. Periconceptional folic acid intake in Nijmegen, Netherlands. Lancet 1999; 353: 292.
39. Lynch SM. Assessment of student pharmacists knowledge concerning folic acid and prevention of birth defects; demonstrates a need for further education. J Nutr 2002; 132: 433-443.
40. Recommendations for use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Mortal Morb Wkly Rep 1992; 41(RR14): 1-7.
41. Society of Obstetricians and Gynecologists of Canada, Genetics Committee. Recommendations on use of folic acid for prevention of neural tube defects. J Soc Obstet Gynecol Canada. 1993: 3: 41-46.
42. US Food and Drug Administration Food Standards: Amendments of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996; 61: 878-8788.
43. Gregory JF. Bioavailability of folate. Eur J Clin Nutr 1997; 51: 554-559.
44. Bureau of Nutrition Sciences, Food Directorate; Health Protection Branch. The addition of vitamins and minerals to foods; proposed policy recommendations. Ottawa Health, Canada 1999.
45. 12, Pantothenic Acid, Biotin and Choline. Washington D.C: National Academy Press 1998: 1-8.
46. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN et al. Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet 1997; 350: 1666-1669.
47. Mills JL. Fortification of foods with folic acid - how much is enough? N Engl J Med 2000; 342: 1422-1445.
48. Folic acid and the prevention of disease: report of the committee on medical aspects of food and nutrition policy. Reports on Health and Social Subjects.50, London: Her Majesty's Stationery Office; 2000.
49. Clark NAC, Fisk NM. Minimal compliance with the department of health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynecol 1994; 101: 709-710.
50. Castilla EE, da Graca Dutra M. Folate awareness among South American woman. Lancet 1997; 349: 735.
51. Honein MA, Paulozzi LJ, Matthews TZ, Ericson JD, Wong E-YC. Impact of folic acid fortification of US food supply on the occurrence of neural tube defects. JAMA 2001; 285: 2981-2986.
52. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2001; 360: 2047-2048.
53. Prasad VL, Dubey JM, Zieman P, Vandenhof ML. Incidence of neural tube defects after folic acid fortification. CMAJ 2002; 167: 241-257.
54. Lawrence MJ, Pettiti DB, Walkens M, Umekubo MA. Trends in serum folate after food fortification. Lancet 2001; 354: 915-916.
55. Cuskelly GJ, Scott JM, Nulty HM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: Implications for the prevention of neural tube defects. Am J Clin Nutr 1999; 70: 234-239.
56. Dayit MM. Report of Workgroup on Non Infectious Diseases. Principal Medical Officer. London: Department of Health. 2000.